Letter to the Editor: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.

Rao, Sudhaker D; Qiu, Shijing; Dhaliwal, Ruban; Bhadada, Sanjay Kumar

Rao, Sudhaker D; Qiu, Shijing; Dhaliwal, Ruban; Bhadada, Sanjay Kumar.

Afiliación

Rao SD; Bone and Mineral Research Laboratory, Henry Ford Hospital, Detroit, Michigan 48202.
Qiu S; Bone and Mineral Research Laboratory, Henry Ford Hospital, Detroit, Michigan 48202.
Dhaliwal R; Department of Endocrinology, Diabetes and Metabolism, State University of New York Upstate Medical University, Syracuse, New York 13210.
Bhadada SK; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.

J Clin Endocrinol Metab ; 102(6): 2111, 2017 06 01.

Article en En | MEDLINE | ID: mdl-28586451

Asunto(s)

Denosumab; Fracturas de la Columna Vertebral; Conservadores de la Densidad Ósea; Humanos; Osteoporosis Posmenopáusica; Fracturas Osteoporóticas

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fracturas de la Columna Vertebral / Denosumab Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Endocrinol Metab Año: 2017 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google